Related Experiment Videos
Pharmacological agents in development for invasive aspergillosis
Elisabeth J Ruijgrok1, Jaques F G M Meis
1Department of Hospital Pharmacy, Erasmus Medical Centre, Rotterdam, The Netherlands. ruijgrok@apdz.azr.nl
Expert Opinion on Emerging Drugs
|July 2, 2005
Summary
New antifungal drugs are in development to combat invasive aspergillosis (IA). This review covers current and emerging antifungal agents for IA treatment and prevention.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Pharmacology
Background:
- Invasive aspergillosis (IA) presents a significant clinical challenge requiring novel antifungal therapies.
- Existing treatments face limitations, driving the need for new drug development.
Purpose of the Study:
- To review currently available antifungal agents for invasive aspergillosis (IA).
- To discuss novel antifungal compounds in development for IA treatment and prophylaxis.
- To classify these agents based on their mechanisms of action.
Main Methods:
- Literature review of antifungal agents for IA.
- Classification of drugs by mechanism of action.
- Analysis of agents in clinical trials and market readiness.
Main Results:
- Several novel antifungal agents are in late-stage clinical trials for IA.
- New drug classes with different mechanisms of action are emerging.
- The pipeline includes agents for both treatment and prevention of IA.
Conclusions:
- The development of new antifungal agents offers promise for managing invasive aspergillosis.
- A diverse range of novel compounds are nearing market entry.
- Understanding mechanisms of action is crucial for effective IA management.